These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 793141

  • 1. Effects of contraceptive pills and intrauterine devices on urinary bladder.
    Zahran MM, Osman MI, Kamel M, Fayad M, Mooro H, Youssef AF.
    Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
    [Abstract] [Full Text] [Related]

  • 2. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 3. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B.
    N Engl J Med; 1983 Apr 14; 308(15):862-7. PubMed ID: 6572785
    [Abstract] [Full Text] [Related]

  • 4. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K, Sami G, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun 14; 5(1):19-24. PubMed ID: 12256026
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Jun 14; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 7. Current status of contraceptive steroids and the intrauterine device.
    Mishell DR.
    Clin Obstet Gynecol; 1974 Mar 14; 17(1):35-51. PubMed ID: 4596680
    [Abstract] [Full Text] [Related]

  • 8. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP, Lawless M, McPherson K, Yeates D.
    Lancet; 1983 Oct 22; 2(8356):930-4. PubMed ID: 6138502
    [Abstract] [Full Text] [Related]

  • 9. Liver function tests in patients on oral progestogens.
    Engineer AD, Gupta V, Tandon P.
    J Obstet Gynaecol India; 1968 Apr 22; 18(2):598-605. PubMed ID: 12331828
    [Abstract] [Full Text] [Related]

  • 10. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K, Kamal I, Talaat MM, Rashad S, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun 22; 5(1):41-65. PubMed ID: 12256027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association between diaphragm use and asymptomatic bacteriuria.
    Peddie BA, Bishop VA, Blake EE, Gorrie SI, Bailey RR, Edwards D.
    Aust N Z J Obstet Gynaecol; 1986 Aug 22; 26(3):225-7. PubMed ID: 3545172
    [Abstract] [Full Text] [Related]

  • 13. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC.
    Fertil Steril; 1978 Nov 22; 30(5):522-33. PubMed ID: 214353
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O, Akinyemi A.
    Int J Gynaecol Obstet; 1989 Oct 22; 30(2):165-70. PubMed ID: 2572488
    [Abstract] [Full Text] [Related]

  • 15. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA, Brenner PF, Kletzky OA, Mishell DR.
    Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817
    [Abstract] [Full Text] [Related]

  • 17. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [Abstract] [Full Text] [Related]

  • 18. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K, Younis MN, Razek SA, Mekkawi TE, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun 15; 5(1):145-51. PubMed ID: 12256025
    [Abstract] [Full Text] [Related]

  • 19. Steroid contraceptives: neuro-psychiatric & electroencephalographic complications.
    Elwan O, Madkour O, Kamal I, Abdallah M.
    J Int Med Res; 1973 Jun 15; 1(6):534-47. PubMed ID: 4806735
    [Abstract] [Full Text] [Related]

  • 20. Adrenocortical function of patients using oral contraceptives.
    Kauppila A, Järvinen PA, Ylöstalo P, Reinilä M.
    Acta Obstet Gynecol Scand; 1974 Jun 15; 53(2):155-9. PubMed ID: 4362662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.